Values First Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Values First Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-5	Closed	-$449	–	236
2024 Q4	$449	Sell	5 -2,057	-100%	-$199K	﹤0.01%	220
2024 Q3	$204K	Sell	2,062 -67	-3%	-$6.58K	0.11%	145
2024 Q2	$197K	Sell	2,129 -53	-2%	-$4.75K	0.12%	146
2024 Q1	$207K	Sell	2,182 -489	-18%	-$45.4K	0.12%	149
2023 Q4	$238K	Buy	2,671 +845	+46%	+$62.8K	0.14%	136
2023 Q3	$133K	Sell	1,826 -30	-2%	-$2.4K	0.09%	145
2023 Q2	$154K	Buy	1,856 +30	+2%	+$2.51K	0.09%	151
2023 Q1	$139K	Sell	1,826 -217	-11%	-$18K	0.09%	154
2022 Q4	$170K	Buy	2,043 +257	+14%	+$20.8K	0.12%	134
2022 Q3	$142K	Buy	1,786 +66	+4%	+$5.56K	0.1%	138
2022 Q2	$128K	Buy	+1,720	New	+$129K	0.09%	141

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Values First Advisors's XBI Position: Q1 2025 in Review

Values First Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2025, closing a stake of 5 shares — an estimated $449 sold.

Values First Advisors first reported a position in XBI in Q2 2022 and held it in 11 quarters. The position peaked at $238K in Q4 2023. 685 funds tracked by Wall St. Rank hold XBI as of Q1 2025.

Values First Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2025 after selling out during the quarter.
Values First Advisors sold 5 State Street SPDR S&P Biotech ETF shares in Q1 2025, an estimated $449.
Values First Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and held it in 11 quarters.
Values First Advisors's State Street SPDR S&P Biotech ETF position peaked at $238K in Q4 2023.
685 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2025.

Based on Values First Advisors's 13F filing for Q1 2025, filed 30 Apr 2025.